Retinal disease drug developer Gyroscope Therapeutics has raised series C funding from investors including Fosun Pharma.

Cambridge Innovation Capital has returned for a series C round for University of Cambridge-linked Gyroscope Therapeutics, which also welcomed back Syncona.

The solid tumour therapy developer secured $21.9m from investors including Dai-ichi Life, Binex, Bigen and Shibuya Kogyo.

The open-source software manager was valued above $800m in a round that included new corporate backer Salesforce Ventures.

Alphabet's CapitalG unit contributed to a series C round valuing the identity verification network provider at $1.5bn.

The Barclays-backed work management platform developer is looking to expand into new verticals after securing series B funding.

Trucking distribution system developer Baton raised $10.5m in a round co-led by Maersk Growth that included Prologis Ventures, Lineage Logistics and RyderVentures.

Chord has paid an undisclosed amount to purchase the customer data sofware provider, which had raised $7.2m from investors including Gradient Ventures last year.

Helsinn and Johnson & Johnson returned to add $21m in extra funding to the $44m series B round the surgical marker developer closed in 2018.

The software engineering education provider has added learning tools to its offering and secured funding from investors including Pearson Ventures.